Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $256.22 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ITI, Inc. | $83.12 | 3 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $50.58 | 3 | $0 (2021) |
| Alkermes, Inc. | $45.43 | 2 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $22.74 | 1 | $0 (2021) |
| Bausch Health US, LLC | $20.43 | 1 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.59 | 1 | $0 (2021) |
| Adlon Therapeutics L.P. | $15.33 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $20.54 | 1 | Alkermes, Inc. ($20.54) |
| 2021 | $235.68 | 11 | ITI, Inc. ($83.12) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: CNS | ||||||
| 11/11/2021 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: CNS | ||||||
| 10/28/2021 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $33.54 | General |
| Category: PSYCHIATRY | ||||||
| 06/09/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2021 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: PSYCHIATRY | ||||||
| 04/28/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $31.08 | General |
| Category: CNS | ||||||
| 04/28/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $1.62 | General |
| Category: CNS | ||||||
| 04/13/2021 | Bausch Health US, LLC | WELLBUTRIN (Drug), APLENZIN | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Neurology | ||||||
| 04/08/2021 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: PSYCHIATRY | ||||||
| 04/01/2021 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Neuroscience | ||||||
| 01/27/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: CNS | ||||||
| 01/06/2021 | Adlon Therapeutics L.P. | ADHANSIA XR (Drug) | Food and Beverage | Cash or cash equivalent | $15.33 | General |
| Category: PRESCRIPTION STIMULANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 70 | 193 | $53,412 | $11,728 |
| 2022 | 2 | 71 | 183 | $50,962 | $10,771 |
| 2021 | 3 | 83 | 211 | $55,644 | $11,348 |
| 2020 | 4 | 83 | 183 | $45,922 | $9,519 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 52 | 118 | $27,612 | $6,046 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 75 | $25,800 | $5,682 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 74 | $25,456 | $5,544 | 21.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 53 | 109 | $25,506 | $5,227 | 20.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 53 | 116 | $27,144 | $5,580 | 20.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 68 | $23,392 | $4,961 | 21.2% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 12 | 27 | $5,108 | $807.25 | 15.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 21 | 62 | $21,328 | $3,920 | 18.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 23 | 47 | $10,998 | $2,344 | 21.3% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 19 | 47 | $7,332 | $1,959 | 26.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 20 | 27 | $6,264 | $1,295 | 20.7% |
About Annette Mancuso, LPC
Annette Mancuso, LPC is a Professional healthcare provider based in Grapevine, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1679694277.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Annette Mancuso, LPC has received a total of $256.22 in payments from pharmaceutical and medical device companies, with $20.54 received in 2023. These payments were reported across 12 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($256.22).
As a Medicare-enrolled provider, Mancuso has provided services to 307 Medicare beneficiaries, totaling 770 services with total Medicare billing of $43,366. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Professional
- Other Specialties Family
- Location Grapevine, TX
- Active Since 04/02/2007
- Last Updated 11/28/2017
- Taxonomy Code 101YP2500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679694277
Products in Payments
- CAPLYTA (Drug) $83.12
- LATUDA (Drug) $50.58
- LYBALVI (Drug) $24.89
- SPRAVATO (Drug) $22.74
- ARISTADA (Drug) $20.54
- WELLBUTRIN (Drug) $20.43
- TRINTELLIX (Drug) $18.59
- ADHANSIA XR (Drug) $15.33
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Professional Doctors in Grapevine
Felicia Bessman, Np, Lpc, NP, LPC
Professional — Payments: $44.47
Dr. Linda Huffhines, Edd, EDD
Professional
Mrs. Shara Green, Lpc, LPC
Professional
Meggan Havelka, Lpc, LPC
Professional
Mrs. Chita Mulholland, Ma, Lpc, MA, LPC
Professional
Kathleene Stevenson, Lpc, LPC
Professional